BioLineRx Initiates Phase 2 Trial for BL-8040 as Novel Stem Cell Mobilization Treatment – Investing News Network (press release) (registration) (blog)
BioLineRx Initiates Phase 2 Trial for BL-8040 as Novel Stem Cell Mobilization TreatmentInvesting News Network (press release) (registration) (blog)BioLineRx Ltd. (NASDAQ:BLRX) announced the initiation of a Phase 2 trial for BL-8040 as a novel approach … Continue reading
